These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31287867)

  • 1. Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
    Yang Z; Bedugnis A; Levinson S; Dinubile M; Stossel T; Lu Q; Kobzik L
    J Infect Dis; 2019 Sep; 220(9):1498-1502. PubMed ID: 31287867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza.
    Yang Z; Bedugnis A; Levinson S; DiNubile M; Stossel T; Lu Q; Kobzik L
    F1000Res; 2019; 8():1860. PubMed ID: 31824672
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.
    Yang Z; Chiou TT; Stossel TP; Kobzik L
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant
    DiNubile MJ; Levinson SL; Stossel TP; Lawrenz MB; Warawa JM
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa236. PubMed ID: 32766380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.
    Tannous A; Levinson SL; Bolognese J; Opal SM; DiNubile MJ
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.
    DiNubile MJ; Parra S; Salomó AC; Levinson SL
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac357. PubMed ID: 35928505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.
    Catteeuw JV; DiNubile MJ
    Clin Infect Pract; 2021 Nov; 12():100088. PubMed ID: 34396087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.
    Bhopale VM; Ruhela D; Brett KD; Nugent NZ; Fraser NK; Levinson SL; DiNubile MJ; Thom SR
    J Appl Physiol (1985); 2021 May; 130(5):1604-1613. PubMed ID: 33764168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.
    Self WH; Wunderink RG; DiNubile MJ; Stossel TP; Levinson SL; Williams DJ; Anderson EJ; Bramley AM; Jain S; Edwards KM; Grijalva CG
    Clin Infect Dis; 2019 Sep; 69(7):1218-1225. PubMed ID: 30561561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
    Fukuoka T; Kawada H; Kitayama A; Koga T; Kubota M; Harasaki T; Kamai Y; Ohya S; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):23-7. PubMed ID: 9449255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of plasma gelsolin administration in a rat model of sepsis.
    Cohen TS; Bucki R; Byfield FJ; Ciccarelli NJ; Rosenberg B; DiNubile MJ; Janmey PA; Margulies SS
    Cytokine; 2011 Jun; 54(3):235-8. PubMed ID: 21420877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with
    Piktel E; Wnorowska U; Cieśluk M; Deptuła P; Prasad SV; Król G; Durnaś B; Namiot A; Markiewicz KH; Niemirowicz-Laskowska K; Wilczewska AZ; Janmey PA; Reszeć J; Bucki R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia.
    Li L; Foo BJW; Kwok KW; Sakamoto N; Mukae H; Izumikawa K; Mandard S; Quenot JP; Lagrost L; Teh WK; Singh Kohli G; Zhu P; Choi H; Buist ML; Seet JE; Yang L; He F; Kwong Chow VT; Tan NS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia.
    Schouten M; van 't Veer C; van den Boogaard FE; Gerlitz B; Grinnell BW; Roelofs JJ; Levi M; van der Poll T
    J Infect Dis; 2010 Nov; 202(10):1600-7. PubMed ID: 20925531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.